data_1jdk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1jdk _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.272 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.32 142.49 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 124.423 1.077 . . . . 0.0 108.292 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -91.45 84.05 5.5 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.392 1.092 . . . . 0.0 108.823 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.52 -79.97 0.08 OUTLIER Glycine 0 CA--C 1.538 1.503 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.92 105.54 5.83 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.285 81.1 p -136.0 -109.87 0.2 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.185 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.19 -80.06 0.53 Allowed Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.424 1.465 . . . . 0.0 112.181 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -77.67 -68.71 0.6 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.18 0.592 . . . . 0.0 111.788 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 tp -147.49 -71.5 0.22 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.665 0.666 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 tp -137.76 90.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 118.493 0.588 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 p -61.93 -60.41 3.67 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 121.321 1.873 . . . . 0.0 112.251 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.0 p -106.04 81.07 1.59 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 124.38 2.038 . . . . 0.0 110.909 -179.289 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.52 99.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -140.67 100.29 3.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.71 -78.35 0.09 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 99.26 4.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p -150.66 161.51 42.45 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.076 0.55 . . . . 0.0 111.12 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.1 113.62 3.19 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -50.32 73.42 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 tp -82.3 -65.77 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.713 0.688 . . . . 0.0 109.747 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -99.04 101.33 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -163.52 115.63 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -135.85 87.22 2.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 122.798 1.285 . . . . 0.0 110.934 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 tp -146.81 98.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -151.39 106.53 3.3 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.68 -88.16 1.55 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -111.51 93.78 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.1 m -155.17 161.6 41.17 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.922 0.889 . . . . 0.0 108.973 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.36 -113.88 0.33 Allowed Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.078 -1.639 . . . . 0.0 112.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -153.29 -58.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.824 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.47 -72.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.228 0.922 . . . . 0.0 113.358 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -146.02 87.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.324 0.966 . . . . 0.0 109.379 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -153.42 103.42 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -149.94 109.72 4.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 124.414 2.054 . . . . 0.0 110.656 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.7 tp -142.22 102.64 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.527 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -88.83 88.42 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.072 0.939 . . . . 0.0 110.484 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.3 -99.8 0.15 Allowed Glycine 0 N--CA 1.479 1.53 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.86 103.52 5.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.4 p -153.83 159.09 41.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.829 0.452 . . . . 0.0 111.617 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.47 115.95 2.16 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.56 -58.23 9.35 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.0 tp -76.07 -58.83 3.05 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.731 0.696 . . . . 0.0 111.313 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.43 102.61 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -124.75 -88.23 0.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 t -161.33 132.6 5.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 119.73 1.15 . . . . 0.0 109.443 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 124.498 2.094 . . . . 0.0 109.945 179.442 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -146.78 97.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -143.49 157.05 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.783 0.802 . . . . 0.0 109.779 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.69 -74.75 1.07 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.13 99.05 2.35 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.257 89.5 p -138.44 -115.97 0.15 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.952 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.58 90.3 0.08 OUTLIER Glycine 0 N--CA 1.479 1.562 0 CA-C-N 120.268 1.394 . . . . 0.0 112.872 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -129.15 -83.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.0 tp -97.36 -71.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.88 138.34 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 65.2 p -80.67 -92.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.438 1.017 . . . . 0.0 112.312 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.8 m -141.24 131.44 24.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.259 1.391 . . . . 0.0 109.218 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 122.957 1.361 . . . . 0.0 111.258 179.192 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.1 tt -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 124.122 0.889 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -147.28 115.3 6.52 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.46 90.49 0.19 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.35 114.85 15.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -144.06 173.56 11.62 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 123.487 0.715 . . . . 0.0 110.648 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.02 -99.1 0.12 Allowed Glycine 0 N--CA 1.482 1.701 0 O-C-N 120.495 -1.378 . . . . 0.0 112.917 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -82.12 -64.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.7 tp -140.15 -58.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.843 0.747 . . . . 0.0 112.259 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -135.64 89.07 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.058 0.844 . . . . 0.0 110.732 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.1 p -115.01 137.28 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.599 0.714 . . . . 0.0 110.226 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.3 m -87.09 106.96 18.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 122.886 1.327 . . . . 0.0 112.424 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp -134.68 93.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 124.236 0.96 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -152.41 124.59 8.11 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.38 -63.53 1.67 Allowed Glycine 0 N--CA 1.492 2.371 0 CA-C-N 116.452 -0.34 . . . . 0.0 113.832 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -102.72 108.44 19.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.335 79.9 p -86.19 -116.74 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 118.399 -0.81 . . . . 0.0 111.087 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 -78.81 1.92 Allowed Glycine 0 N--CA 1.485 1.945 0 CA-C-N 120.261 1.391 . . . . 0.0 114.666 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -110.64 -163.6 0.86 Allowed 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.115 0.966 . . . . 0.0 112.035 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.55 -25.06 36.16 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.79 96.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -136.1 94.39 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -139.43 103.29 4.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 122.799 1.285 . . . . 0.0 112.528 -179.833 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.07 97.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -149.13 109.12 4.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.47 76.95 0.06 OUTLIER Glycine 0 N--CA 1.48 1.597 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.34 122.99 3.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -148.22 167.44 25.1 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.415 0.686 . . . . 0.0 110.465 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.26 -99.51 0.13 Allowed Glycine 0 N--CA 1.48 1.619 0 O-C-N 120.326 -1.484 . . . . 0.0 112.8 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -91.36 -68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.322 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -145.99 -66.08 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.159 0.89 . . . . 0.0 110.963 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.337 9.7 tp -95.51 79.86 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.882 0.764 . . . . 0.0 112.112 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -152.1 131.14 12.62 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.095 0.474 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 m -100.42 112.61 24.98 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 124.195 1.95 . . . . 0.0 111.999 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.247 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.7 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -152.11 102.97 2.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.26 71.88 0.02 OUTLIER Glycine 0 CA--C 1.54 1.626 0 CA-C-O 119.634 -0.536 . . . . 0.0 114.026 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.42 101.73 2.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.8 p -129.71 178.75 6.27 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.286 0.635 . . . . 0.0 111.798 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.37 -95.7 0.1 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -83.08 -65.24 1.03 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 122.956 0.502 . . . . 0.0 110.425 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 tp -121.78 -83.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 109.18 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.4 m -141.39 -72.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.634 1.106 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -125.71 75.73 1.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.701 0.762 . . . . 0.0 111.13 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 123.203 1.477 . . . . 0.0 109.957 179.458 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 tp -147.9 103.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -126.86 88.31 2.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.64 -64.44 2.16 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.368 0.0 OUTLIER -133.74 -33.89 1.05 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.7 p -150.81 -163.97 1.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.583 1.083 . . . . 0.0 110.714 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.12 68.86 3.45 Favored Glycine 0 N--CA 1.487 2.056 0 O-C-N 121.004 -1.06 . . . . 0.0 113.831 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -151.82 124.83 8.61 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.32 4.4 pp -51.17 -26.94 7.59 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 119.932 3.308 . . . . 0.0 119.932 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.279 10.7 tp -133.3 84.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.433 1.015 . . . . 0.0 110.299 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.42 101.71 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.6 m -139.41 110.82 7.03 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 124.308 2.004 . . . . 0.0 110.73 -179.881 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.288 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -145.74 96.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 124.024 0.828 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -150.75 103.54 3.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.11 -74.74 2.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 112.116 -0.393 . . . . 0.0 112.116 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.274 5.0 tm-20 -119.06 -60.05 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.447 1.099 . . . . 0.0 110.358 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.271 91.5 p -150.06 -138.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.721 0.808 . . . . 0.0 108.866 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.26 94.1 0.09 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.777 -1.202 . . . . 0.0 112.0 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.256 21.6 ptmt -143.84 -68.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.495 0.718 . . . . 0.0 109.796 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 -71.43 0.74 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 tp -149.43 90.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -137.13 106.01 5.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -142.23 97.9 3.21 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.217 1.961 . . . . 0.0 111.144 -179.642 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.07 96.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -155.38 115.5 3.76 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.43 100.26 2.64 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 121.849 -0.532 . . . . 0.0 114.246 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.88 115.11 3.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.1 p -131.01 161.82 31.12 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.357 0.663 . . . . 0.0 110.593 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.33 -93.07 0.09 OUTLIER Glycine 0 N--CA 1.482 1.734 0 O-C-N 120.343 -1.473 . . . . 0.0 112.741 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 61.0 pttt -70.69 -67.22 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.36 1.5 pt? -149.58 -59.84 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.731 0.813 . . . . 0.0 110.024 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -129.04 90.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -73.38 131.01 41.37 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 121.544 1.975 . . . . 0.0 114.172 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.6 m -141.18 98.91 3.47 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 122.911 1.338 . . . . 0.0 112.46 -179.604 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 tp -146.37 99.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -155.48 108.89 2.78 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.13 91.94 1.51 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.84 111.8 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.2 p -115.81 82.15 1.72 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.54 -92.84 0.9 Allowed Glycine 0 N--CA 1.484 1.888 0 O-C-N 120.838 -1.164 . . . . 0.0 113.28 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -97.71 -70.81 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.994 0.518 . . . . 0.0 111.072 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -141.67 -68.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.866 0.757 . . . . 0.0 109.478 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -101.82 90.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.8 m -141.33 110.64 6.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -138.51 91.49 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 122.753 1.263 . . . . 0.0 113.189 -179.573 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.27 97.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -151.47 109.74 3.75 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.01 105.22 3.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.41 113.52 17.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.273 93.9 p -136.69 -126.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.372 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 -78.82 1.97 Allowed Glycine 0 N--CA 1.487 2.043 0 CA-C-N 120.062 1.301 . . . . 0.0 112.174 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -85.7 153.24 22.47 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.937 0.895 . . . . 0.0 110.117 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 4.5 pp -55.57 -22.12 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.252 0.0 OUTLIER -134.87 90.82 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 t -148.54 131.56 16.27 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.485 0.714 . . . . 0.0 109.089 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.0 m -94.8 102.71 14.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 124.103 1.906 . . . . 0.0 108.992 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.218 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 99.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 124.158 0.911 . . . . 0.0 108.641 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -131.29 91.28 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.52 -82.96 0.05 OUTLIER Glycine 0 N--CA 1.481 1.657 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -151.16 94.87 2.1 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -153.04 166.59 31.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.996 0.518 . . . . 0.0 110.849 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.96 114.36 2.87 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.69 -55.84 25.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.58 -61.06 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.13 0.572 . . . . 0.0 110.449 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.57 101.19 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.011 0.925 . . . . 0.0 109.24 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.6 m -124.53 -74.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p -133.25 -61.55 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.92 0.888 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 122.808 1.29 . . . . 0.0 112.842 179.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.2 tp -144.1 106.02 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -93.26 84.48 4.79 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.373 1.083 . . . . 0.0 108.22 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.39 -72.24 0.04 OUTLIER Glycine 0 CA--C 1.538 1.528 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.974 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.35 128.76 6.13 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 83.3 p -127.02 -129.05 0.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.25 70.49 0.03 OUTLIER Glycine 0 N--CA 1.484 1.893 0 CA-C-N 119.969 1.259 . . . . 0.0 114.434 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.9 -76.64 0.23 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.2 tp -125.89 -80.07 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -78.59 117.79 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.301 13.6 t -75.83 -59.15 2.88 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.4 m -90.11 77.28 6.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.614 1.097 . . . . 0.0 110.257 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 122.944 1.354 . . . . 0.0 111.071 -179.394 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.58 99.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.151 0.907 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -128.44 89.32 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.61 -78.16 0.07 OUTLIER Glycine 0 N--CA 1.481 1.671 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -116.31 83.3 1.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.1 p -154.24 104.9 2.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.44 120.56 0.68 Allowed Glycine 0 CA--C 1.541 1.695 0 CA-C-N 121.065 1.757 . . . . 0.0 111.448 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -58.89 -52.97 63.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 tp -78.29 -75.96 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 tt -90.61 125.13 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -62.99 -69.22 0.28 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.194 1.361 . . . . 0.0 112.269 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.9 m -150.04 107.05 3.56 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 122.915 1.341 . . . . 0.0 111.428 179.53 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.2 102.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -93.45 82.91 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.468 1.128 . . . . 0.0 109.203 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.67 -83.84 0.05 OUTLIER Glycine 0 CA--C 1.537 1.407 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.962 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.51 94.9 4.34 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -160.98 149.54 16.24 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 123.853 0.861 . . . . 0.0 110.091 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.04 125.98 4.65 Favored Glycine 0 CA--C 1.546 1.997 0 O-C-N 120.649 -1.282 . . . . 0.0 112.085 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -64.88 -50.88 64.83 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 mt -77.21 -59.1 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.73 0.696 . . . . 0.0 111.15 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.1 mm -107.71 92.36 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 p -81.46 100.06 9.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.838 1.199 . . . . 0.0 109.489 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 p -91.37 -63.36 1.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.502 2.096 . . . . 0.0 108.796 179.345 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 tp -147.69 105.13 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -138.38 95.29 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.34 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.9 59.52 0.73 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -179.1 -97.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.62 -82.39 1.42 Allowed Glycine 0 C--N 1.355 1.603 0 CA-C-N 119.566 1.075 . . . . 0.0 115.716 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -147.83 -57.97 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -128.55 -72.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.302 0.956 . . . . 0.0 109.405 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.3 tt -69.79 136.18 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 118.788 0.722 . . . . 0.0 110.959 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -81.39 86.84 6.22 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.062 1.301 . . . . 0.0 110.042 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 96.7 m -140.87 89.6 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 124.533 2.111 . . . . 0.0 110.895 -179.268 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.212 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -145.13 87.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 124.135 0.897 . . . . 0.0 108.718 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -113.85 100.69 8.63 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.42 -89.56 2.11 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 111.992 -0.443 . . . . 0.0 111.992 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.93 97.07 6.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 p -161.53 178.74 8.81 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.42 0.688 . . . . 0.0 111.249 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.72 -76.77 0.12 Allowed Glycine 0 N--CA 1.482 1.729 0 O-C-N 120.78 -1.2 . . . . 0.0 112.689 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -70.95 -60.42 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.47 -98.22 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.25 6.6 tp -146.01 94.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.266 0.939 . . . . 0.0 109.843 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -126.17 -72.63 0.65 Allowed 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.6 t -152.64 133.39 13.95 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.524 0.73 . . . . 0.0 110.099 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 122.828 1.299 . . . . 0.0 112.394 179.841 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm -146.91 109.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -153.34 110.55 3.48 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.54 90.65 1.64 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-O 120.169 -0.24 . . . . 0.0 112.887 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.61 110.62 4.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.7 p -118.06 85.32 2.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.78 -91.76 0.78 Allowed Glycine 0 C--N 1.36 1.871 0 CA-C-N 119.763 1.165 . . . . 0.0 113.063 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -98.46 -80.91 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.651 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.64 -72.63 0.68 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -108.21 111.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.2 t -151.1 126.02 9.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.3 p -136.24 76.28 1.59 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 124.159 1.933 . . . . 0.0 110.987 -179.567 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.91 100.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -142.41 106.9 4.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.65 94.13 0.56 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -118.51 72.31 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.954 0.883 . . . . 0.0 109.644 179.32 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.2 p -163.14 87.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 68.99 1.48 Allowed Glycine 0 N--CA 1.491 2.313 0 CA-C-N 121.396 1.907 . . . . 0.0 112.6 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -141.43 141.85 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.348 0.659 . . . . 0.0 110.884 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -38.55 81.43 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 177.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.5 tp -119.65 99.28 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 176.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -84.68 98.41 10.19 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.49 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -92.54 106.48 18.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.782 1.277 . . . . 0.0 113.468 -179.564 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.04 132.52 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.264 0.978 . . . . 0.0 111.599 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -93.03 86.79 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.71 -110.43 0.44 Allowed Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.26 130.27 3.45 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.583 0.691 . . . . 0.0 110.943 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.261 95.7 p -141.23 -121.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.53 78.48 0.11 Allowed Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -152.09 -166.07 2.39 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 123.881 0.872 . . . . 0.0 110.545 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.28 -25.35 67.04 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 177.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.45 94.28 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.7 m -119.73 104.29 10.11 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.5 m -91.87 119.46 31.67 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 124.434 2.064 . . . . 0.0 108.861 179.675 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.367 9.1 tp -94.64 74.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 . . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -143.24 90.45 2.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.709 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.93 100.95 2.34 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.4 93.23 4.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.376 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -158.19 159.42 36.1 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.325 0.65 . . . . 0.0 110.488 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.21 115.08 3.75 Favored Glycine 0 N--CA 1.485 1.915 0 O-C-N 120.88 -1.137 . . . . 0.0 112.033 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.03 -44.86 95.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.073 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 tp -74.64 -48.51 25.92 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 123.525 0.73 . . . . 0.0 112.509 177.847 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tp -128.72 101.7 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -74.73 103.57 5.05 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.408 1.004 . . . . 0.0 108.723 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -125.01 112.54 16.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.265 1.983 . . . . 0.0 111.499 -179.722 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp -149.23 103.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -127.35 92.37 3.49 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.37 -117.09 0.51 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -145.36 131.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 117.521 0.66 . . . . 0.0 111.336 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.272 20.5 m -130.29 -113.01 0.25 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 117.133 -1.413 . . . . 0.0 107.199 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.8 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.483 1.808 0 CA-C-N 122.141 2.246 . . . . 0.0 116.915 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -52.41 -60.51 3.15 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -75.62 -62.07 1.71 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.127 0.876 . . . . 0.0 112.45 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 tp -150.6 128.06 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 p -76.57 86.57 3.26 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 121.199 1.818 . . . . 0.0 112.033 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 t -168.77 139.11 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.807 1.243 . . . . 0.0 107.816 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 122.801 1.286 . . . . 0.0 112.765 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.272 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.32 142.49 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 124.423 1.077 . . . . 0.0 108.292 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -91.45 84.05 5.5 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.392 1.092 . . . . 0.0 108.823 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.52 -79.97 0.08 OUTLIER Glycine 0 CA--C 1.538 1.503 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.92 105.54 5.83 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.285 81.1 p -136.0 -109.87 0.2 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.185 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.19 -80.06 0.53 Allowed Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.424 1.465 . . . . 0.0 112.181 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -77.67 -68.71 0.6 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.18 0.592 . . . . 0.0 111.788 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 tp -147.49 -71.5 0.22 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.665 0.666 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 tp -137.76 90.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 118.493 0.588 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 p -61.93 -60.41 3.67 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 121.321 1.873 . . . . 0.0 112.251 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.0 p -106.04 81.07 1.59 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 124.38 2.038 . . . . 0.0 110.909 -179.289 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.52 99.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -140.67 100.29 3.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.71 -78.35 0.09 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 99.26 4.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p -150.66 161.51 42.45 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.076 0.55 . . . . 0.0 111.12 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.1 113.62 3.19 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -50.32 73.42 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 tp -82.3 -65.77 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.713 0.688 . . . . 0.0 109.747 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -99.04 101.33 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -163.52 115.63 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -135.85 87.22 2.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 122.798 1.285 . . . . 0.0 110.934 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 tp -146.81 98.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -151.39 106.53 3.3 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.68 -88.16 1.55 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -111.51 93.78 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.1 m -155.17 161.6 41.17 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.922 0.889 . . . . 0.0 108.973 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.36 -113.88 0.33 Allowed Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.078 -1.639 . . . . 0.0 112.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -153.29 -58.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.824 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.47 -72.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.228 0.922 . . . . 0.0 113.358 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -146.02 87.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.324 0.966 . . . . 0.0 109.379 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -153.42 103.42 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -149.94 109.72 4.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 124.414 2.054 . . . . 0.0 110.656 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.7 tp -142.22 102.64 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.527 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -88.83 88.42 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.072 0.939 . . . . 0.0 110.484 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.3 -99.8 0.15 Allowed Glycine 0 N--CA 1.479 1.53 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.86 103.52 5.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.4 p -153.83 159.09 41.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.829 0.452 . . . . 0.0 111.617 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.47 115.95 2.16 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.56 -58.23 9.35 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.0 tp -76.07 -58.83 3.05 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.731 0.696 . . . . 0.0 111.313 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.43 102.61 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -124.75 -88.23 0.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 t -161.33 132.6 5.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 119.73 1.15 . . . . 0.0 109.443 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 124.498 2.094 . . . . 0.0 109.945 179.442 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -146.78 97.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -143.49 157.05 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.783 0.802 . . . . 0.0 109.779 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.69 -74.75 1.07 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.13 99.05 2.35 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.257 89.5 p -138.44 -115.97 0.15 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.952 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.58 90.3 0.08 OUTLIER Glycine 0 N--CA 1.479 1.562 0 CA-C-N 120.268 1.394 . . . . 0.0 112.872 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -129.15 -83.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.0 tp -97.36 -71.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.88 138.34 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 65.2 p -80.67 -92.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.438 1.017 . . . . 0.0 112.312 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.8 m -141.24 131.44 24.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.259 1.391 . . . . 0.0 109.218 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 122.957 1.361 . . . . 0.0 111.258 179.192 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.1 tt -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 124.122 0.889 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -147.28 115.3 6.52 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.46 90.49 0.19 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.35 114.85 15.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -144.06 173.56 11.62 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 123.487 0.715 . . . . 0.0 110.648 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.02 -99.1 0.12 Allowed Glycine 0 N--CA 1.482 1.701 0 O-C-N 120.495 -1.378 . . . . 0.0 112.917 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -82.12 -64.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.7 tp -140.15 -58.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.843 0.747 . . . . 0.0 112.259 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -135.64 89.07 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.058 0.844 . . . . 0.0 110.732 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.1 p -115.01 137.28 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.599 0.714 . . . . 0.0 110.226 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.3 m -87.09 106.96 18.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 122.886 1.327 . . . . 0.0 112.424 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp -134.68 93.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 124.236 0.96 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -152.41 124.59 8.11 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.38 -63.53 1.67 Allowed Glycine 0 N--CA 1.492 2.371 0 CA-C-N 116.452 -0.34 . . . . 0.0 113.832 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -102.72 108.44 19.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.335 79.9 p -86.19 -116.74 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 118.399 -0.81 . . . . 0.0 111.087 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 -78.81 1.92 Allowed Glycine 0 N--CA 1.485 1.945 0 CA-C-N 120.261 1.391 . . . . 0.0 114.666 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -110.64 -163.6 0.86 Allowed 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.115 0.966 . . . . 0.0 112.035 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.55 -25.06 36.16 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.79 96.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -136.1 94.39 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -139.43 103.29 4.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 122.799 1.285 . . . . 0.0 112.528 -179.833 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.07 97.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -149.13 109.12 4.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.47 76.95 0.06 OUTLIER Glycine 0 N--CA 1.48 1.597 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.34 122.99 3.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -148.22 167.44 25.1 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.415 0.686 . . . . 0.0 110.465 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.26 -99.51 0.13 Allowed Glycine 0 N--CA 1.48 1.619 0 O-C-N 120.326 -1.484 . . . . 0.0 112.8 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -91.36 -68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.322 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -145.99 -66.08 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.159 0.89 . . . . 0.0 110.963 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.337 9.7 tp -95.51 79.86 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.882 0.764 . . . . 0.0 112.112 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -152.1 131.14 12.62 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.095 0.474 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 m -100.42 112.61 24.98 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 124.195 1.95 . . . . 0.0 111.999 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.247 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.7 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -152.11 102.97 2.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.26 71.88 0.02 OUTLIER Glycine 0 CA--C 1.54 1.626 0 CA-C-O 119.634 -0.536 . . . . 0.0 114.026 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.42 101.73 2.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.8 p -129.71 178.75 6.27 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.286 0.635 . . . . 0.0 111.798 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.37 -95.7 0.1 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -83.08 -65.24 1.03 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 122.956 0.502 . . . . 0.0 110.425 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 tp -121.78 -83.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 109.18 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.4 m -141.39 -72.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.634 1.106 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -125.71 75.73 1.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.701 0.762 . . . . 0.0 111.13 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 123.203 1.477 . . . . 0.0 109.957 179.458 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 tp -147.9 103.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -126.86 88.31 2.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.64 -64.44 2.16 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.368 0.0 OUTLIER -133.74 -33.89 1.05 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.7 p -150.81 -163.97 1.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.583 1.083 . . . . 0.0 110.714 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.12 68.86 3.45 Favored Glycine 0 N--CA 1.487 2.056 0 O-C-N 121.004 -1.06 . . . . 0.0 113.831 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -151.82 124.83 8.61 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.32 4.4 pp -51.17 -26.94 7.59 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 119.932 3.308 . . . . 0.0 119.932 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.279 10.7 tp -133.3 84.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.433 1.015 . . . . 0.0 110.299 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.42 101.71 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.6 m -139.41 110.82 7.03 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 124.308 2.004 . . . . 0.0 110.73 -179.881 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.288 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -145.74 96.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 124.024 0.828 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -150.75 103.54 3.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.11 -74.74 2.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 112.116 -0.393 . . . . 0.0 112.116 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.274 5.0 tm-20 -119.06 -60.05 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.447 1.099 . . . . 0.0 110.358 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.271 91.5 p -150.06 -138.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.721 0.808 . . . . 0.0 108.866 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.26 94.1 0.09 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.777 -1.202 . . . . 0.0 112.0 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.256 21.6 ptmt -143.84 -68.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.495 0.718 . . . . 0.0 109.796 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 -71.43 0.74 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 tp -149.43 90.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -137.13 106.01 5.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -142.23 97.9 3.21 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.217 1.961 . . . . 0.0 111.144 -179.642 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.07 96.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -155.38 115.5 3.76 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.43 100.26 2.64 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 121.849 -0.532 . . . . 0.0 114.246 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.88 115.11 3.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.1 p -131.01 161.82 31.12 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.357 0.663 . . . . 0.0 110.593 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.33 -93.07 0.09 OUTLIER Glycine 0 N--CA 1.482 1.734 0 O-C-N 120.343 -1.473 . . . . 0.0 112.741 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 61.0 pttt -70.69 -67.22 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.36 1.5 pt? -149.58 -59.84 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.731 0.813 . . . . 0.0 110.024 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -129.04 90.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -73.38 131.01 41.37 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 121.544 1.975 . . . . 0.0 114.172 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.6 m -141.18 98.91 3.47 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 122.911 1.338 . . . . 0.0 112.46 -179.604 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 tp -146.37 99.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -155.48 108.89 2.78 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.13 91.94 1.51 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.84 111.8 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.2 p -115.81 82.15 1.72 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.54 -92.84 0.9 Allowed Glycine 0 N--CA 1.484 1.888 0 O-C-N 120.838 -1.164 . . . . 0.0 113.28 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -97.71 -70.81 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.994 0.518 . . . . 0.0 111.072 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -141.67 -68.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.866 0.757 . . . . 0.0 109.478 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -101.82 90.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.8 m -141.33 110.64 6.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -138.51 91.49 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 122.753 1.263 . . . . 0.0 113.189 -179.573 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.27 97.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -151.47 109.74 3.75 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.01 105.22 3.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.41 113.52 17.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.273 93.9 p -136.69 -126.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.372 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 -78.82 1.97 Allowed Glycine 0 N--CA 1.487 2.043 0 CA-C-N 120.062 1.301 . . . . 0.0 112.174 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -85.7 153.24 22.47 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.937 0.895 . . . . 0.0 110.117 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 4.5 pp -55.57 -22.12 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.252 0.0 OUTLIER -134.87 90.82 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 t -148.54 131.56 16.27 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.485 0.714 . . . . 0.0 109.089 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.0 m -94.8 102.71 14.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 124.103 1.906 . . . . 0.0 108.992 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.218 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 99.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 124.158 0.911 . . . . 0.0 108.641 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -131.29 91.28 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.52 -82.96 0.05 OUTLIER Glycine 0 N--CA 1.481 1.657 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -151.16 94.87 2.1 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -153.04 166.59 31.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.996 0.518 . . . . 0.0 110.849 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.96 114.36 2.87 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.69 -55.84 25.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.58 -61.06 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.13 0.572 . . . . 0.0 110.449 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.57 101.19 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.011 0.925 . . . . 0.0 109.24 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.6 m -124.53 -74.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p -133.25 -61.55 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.92 0.888 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 122.808 1.29 . . . . 0.0 112.842 179.68 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.2 tp -144.1 106.02 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -93.26 84.48 4.79 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.373 1.083 . . . . 0.0 108.22 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.39 -72.24 0.04 OUTLIER Glycine 0 CA--C 1.538 1.528 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.974 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.35 128.76 6.13 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 83.3 p -127.02 -129.05 0.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.25 70.49 0.03 OUTLIER Glycine 0 N--CA 1.484 1.893 0 CA-C-N 119.969 1.259 . . . . 0.0 114.434 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.9 -76.64 0.23 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.2 tp -125.89 -80.07 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -78.59 117.79 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.301 13.6 t -75.83 -59.15 2.88 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.4 m -90.11 77.28 6.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.614 1.097 . . . . 0.0 110.257 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 122.944 1.354 . . . . 0.0 111.071 -179.394 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.58 99.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.151 0.907 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -128.44 89.32 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.61 -78.16 0.07 OUTLIER Glycine 0 N--CA 1.481 1.671 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -116.31 83.3 1.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.1 p -154.24 104.9 2.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.44 120.56 0.68 Allowed Glycine 0 CA--C 1.541 1.695 0 CA-C-N 121.065 1.757 . . . . 0.0 111.448 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -58.89 -52.97 63.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 tp -78.29 -75.96 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 tt -90.61 125.13 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -62.99 -69.22 0.28 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.194 1.361 . . . . 0.0 112.269 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.9 m -150.04 107.05 3.56 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 122.915 1.341 . . . . 0.0 111.428 179.53 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.2 102.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -93.45 82.91 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.468 1.128 . . . . 0.0 109.203 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.67 -83.84 0.05 OUTLIER Glycine 0 CA--C 1.537 1.407 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.962 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.51 94.9 4.34 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -160.98 149.54 16.24 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 123.853 0.861 . . . . 0.0 110.091 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.04 125.98 4.65 Favored Glycine 0 CA--C 1.546 1.997 0 O-C-N 120.649 -1.282 . . . . 0.0 112.085 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -64.88 -50.88 64.83 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 mt -77.21 -59.1 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.73 0.696 . . . . 0.0 111.15 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.1 mm -107.71 92.36 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 p -81.46 100.06 9.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.838 1.199 . . . . 0.0 109.489 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 p -91.37 -63.36 1.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.502 2.096 . . . . 0.0 108.796 179.345 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 tp -147.69 105.13 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -138.38 95.29 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.34 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.9 59.52 0.73 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -179.1 -97.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.62 -82.39 1.42 Allowed Glycine 0 C--N 1.355 1.603 0 CA-C-N 119.566 1.075 . . . . 0.0 115.716 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -147.83 -57.97 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -128.55 -72.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.302 0.956 . . . . 0.0 109.405 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.3 tt -69.79 136.18 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 118.788 0.722 . . . . 0.0 110.959 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -81.39 86.84 6.22 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.062 1.301 . . . . 0.0 110.042 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 96.7 m -140.87 89.6 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 124.533 2.111 . . . . 0.0 110.895 -179.268 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.212 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -145.13 87.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 124.135 0.897 . . . . 0.0 108.718 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -113.85 100.69 8.63 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.42 -89.56 2.11 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 111.992 -0.443 . . . . 0.0 111.992 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.93 97.07 6.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 p -161.53 178.74 8.81 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.42 0.688 . . . . 0.0 111.249 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.72 -76.77 0.12 Allowed Glycine 0 N--CA 1.482 1.729 0 O-C-N 120.78 -1.2 . . . . 0.0 112.689 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -70.95 -60.42 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.47 -98.22 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.25 6.6 tp -146.01 94.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.266 0.939 . . . . 0.0 109.843 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -126.17 -72.63 0.65 Allowed 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.6 t -152.64 133.39 13.95 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.524 0.73 . . . . 0.0 110.099 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 122.828 1.299 . . . . 0.0 112.394 179.841 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm -146.91 109.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -153.34 110.55 3.48 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.54 90.65 1.64 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-O 120.169 -0.24 . . . . 0.0 112.887 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.61 110.62 4.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.7 p -118.06 85.32 2.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.78 -91.76 0.78 Allowed Glycine 0 C--N 1.36 1.871 0 CA-C-N 119.763 1.165 . . . . 0.0 113.063 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -98.46 -80.91 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.651 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.64 -72.63 0.68 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -108.21 111.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.2 t -151.1 126.02 9.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.3 p -136.24 76.28 1.59 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 124.159 1.933 . . . . 0.0 110.987 -179.567 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.91 100.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -142.41 106.9 4.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.65 94.13 0.56 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -118.51 72.31 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.954 0.883 . . . . 0.0 109.644 179.32 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.2 p -163.14 87.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 68.99 1.48 Allowed Glycine 0 N--CA 1.491 2.313 0 CA-C-N 121.396 1.907 . . . . 0.0 112.6 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -141.43 141.85 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.348 0.659 . . . . 0.0 110.884 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -38.55 81.43 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 177.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.5 tp -119.65 99.28 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 176.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -84.68 98.41 10.19 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.49 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -92.54 106.48 18.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.782 1.277 . . . . 0.0 113.468 -179.564 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.04 132.52 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.264 0.978 . . . . 0.0 111.599 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -93.03 86.79 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.71 -110.43 0.44 Allowed Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.26 130.27 3.45 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.583 0.691 . . . . 0.0 110.943 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.261 95.7 p -141.23 -121.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.53 78.48 0.11 Allowed Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -152.09 -166.07 2.39 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 123.881 0.872 . . . . 0.0 110.545 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.28 -25.35 67.04 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 177.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.45 94.28 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.7 m -119.73 104.29 10.11 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.5 m -91.87 119.46 31.67 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 124.434 2.064 . . . . 0.0 108.861 179.675 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.367 9.1 tp -94.64 74.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 . . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -143.24 90.45 2.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.709 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.93 100.95 2.34 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.4 93.23 4.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.376 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -158.19 159.42 36.1 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.325 0.65 . . . . 0.0 110.488 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.21 115.08 3.75 Favored Glycine 0 N--CA 1.485 1.915 0 O-C-N 120.88 -1.137 . . . . 0.0 112.033 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.03 -44.86 95.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.073 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 tp -74.64 -48.51 25.92 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 123.525 0.73 . . . . 0.0 112.509 177.847 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tp -128.72 101.7 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -74.73 103.57 5.05 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.408 1.004 . . . . 0.0 108.723 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -125.01 112.54 16.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.265 1.983 . . . . 0.0 111.499 -179.722 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp -149.23 103.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -127.35 92.37 3.49 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.37 -117.09 0.51 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -145.36 131.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 117.521 0.66 . . . . 0.0 111.336 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.272 20.5 m -130.29 -113.01 0.25 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 117.133 -1.413 . . . . 0.0 107.199 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.8 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.483 1.808 0 CA-C-N 122.141 2.246 . . . . 0.0 116.915 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -52.41 -60.51 3.15 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -75.62 -62.07 1.71 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.127 0.876 . . . . 0.0 112.45 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 tp -150.6 128.06 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 p -76.57 86.57 3.26 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 121.199 1.818 . . . . 0.0 112.033 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 t -168.77 139.11 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.807 1.243 . . . . 0.0 107.816 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 122.801 1.286 . . . . 0.0 112.765 179.866 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.272 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -121.32 142.49 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 124.423 1.077 . . . . 0.0 108.292 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -91.45 84.05 5.5 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.392 1.092 . . . . 0.0 108.823 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 172.52 -79.97 0.08 OUTLIER Glycine 0 CA--C 1.538 1.503 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -136.92 105.54 5.83 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.285 81.1 p -136.0 -109.87 0.2 Allowed 'General case' 0 N--CA 1.497 1.9 0 CA-C-O 118.036 -0.983 . . . . 0.0 110.185 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.19 -80.06 0.53 Allowed Glycine 0 N--CA 1.484 1.886 0 CA-C-N 120.424 1.465 . . . . 0.0 112.181 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -77.67 -68.71 0.6 Allowed 'General case' 0 CA--C 1.565 1.55 0 C-N-CA 123.18 0.592 . . . . 0.0 111.788 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.2 tp -147.49 -71.5 0.22 Allowed 'General case' 0 N--CA 1.488 1.451 0 CA-C-N 118.665 0.666 . . . . 0.0 109.594 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.4 tp -137.76 90.49 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 CA-C-N 118.493 0.588 . . . . 0.0 109.89 -179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 47.5 p -61.93 -60.41 3.67 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 121.321 1.873 . . . . 0.0 112.251 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 65.0 p -106.04 81.07 1.59 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.196 0 CA-C-O 124.38 2.038 . . . . 0.0 110.909 -179.289 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.176 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.52 99.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -140.67 100.29 3.82 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 171.71 -78.35 0.09 OUTLIER Glycine 0 N--CA 1.48 1.631 0 N-CA-C 111.111 -0.795 . . . . 0.0 111.111 -179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -132.48 99.26 4.6 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 97.1 p -150.66 161.51 42.45 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 123.076 0.55 . . . . 0.0 111.12 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 113.1 113.62 3.19 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.46 -50.32 73.42 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.6 tp -82.3 -65.77 0.97 Allowed 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 118.713 0.688 . . . . 0.0 109.747 178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -99.04 101.33 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 8.8 t -163.52 115.63 1.46 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.0 m -135.85 87.22 2.29 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 122.798 1.285 . . . . 0.0 110.934 -179.496 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 tp -146.81 98.72 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.2 t-105 -151.39 106.53 3.3 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.68 -88.16 1.55 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 109.639 -1.385 . . . . 0.0 109.639 179.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -111.51 93.78 4.64 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.1 m -155.17 161.6 41.17 Favored 'General case' 0 CA--C 1.572 1.815 0 C-N-CA 123.922 0.889 . . . . 0.0 108.973 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -173.36 -113.88 0.33 Allowed Glycine 0 N--CA 1.481 1.647 0 O-C-N 120.078 -1.639 . . . . 0.0 112.85 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -153.29 -58.66 0.13 Allowed 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.824 -179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 39.7 tp -69.47 -72.09 0.2 Allowed 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 119.228 0.922 . . . . 0.0 113.358 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.271 0.0 OUTLIER -146.02 87.14 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-N 119.324 0.966 . . . . 0.0 109.379 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.8 m -153.42 103.42 2.67 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.8 m -149.94 109.72 4.07 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 124.414 2.054 . . . . 0.0 110.656 -179.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.194 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.7 tp -142.22 102.64 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.527 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -88.83 88.42 7.59 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 122.072 0.939 . . . . 0.0 110.484 -178.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.3 -99.8 0.15 Allowed Glycine 0 N--CA 1.479 1.53 0 N-CA-C 109.191 -1.563 . . . . 0.0 109.191 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -134.86 103.52 5.64 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 77.4 p -153.83 159.09 41.71 Favored 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 122.829 0.452 . . . . 0.0 111.617 179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.47 115.95 2.16 Favored Glycine 0 CA--C 1.543 1.784 0 N-CA-C 109.803 -1.319 . . . . 0.0 109.803 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -60.56 -58.23 9.35 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 45.0 tp -76.07 -58.83 3.05 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 118.731 0.696 . . . . 0.0 111.313 178.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.4 pp -110.43 102.61 14.23 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.553 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.5 m -124.75 -88.23 0.6 Allowed 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.4 t -161.33 132.6 5.43 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 119.73 1.15 . . . . 0.0 109.443 -179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 124.498 2.094 . . . . 0.0 109.945 179.442 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.236 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -146.78 97.84 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.3 m-90 -143.49 157.05 44.75 Favored 'General case' 0 N--CA 1.496 1.825 0 CA-C-O 121.783 0.802 . . . . 0.0 109.779 -179.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.69 -74.75 1.07 Allowed Glycine 0 N--CA 1.495 2.615 0 N-CA-C 109.204 -1.559 . . . . 0.0 109.204 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -153.13 99.05 2.35 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.257 89.5 p -138.44 -115.97 0.15 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-O 118.384 -0.817 . . . . 0.0 110.952 -178.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 174.58 90.3 0.08 OUTLIER Glycine 0 N--CA 1.479 1.562 0 CA-C-N 120.268 1.394 . . . . 0.0 112.872 -179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.0 tppt? -129.15 -83.52 0.57 Allowed 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 178.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.0 tp -97.36 -71.49 0.68 Allowed 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 105.32 -2.104 . . . . 0.0 105.32 176.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.3 tt -113.88 138.34 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.258 65.2 p -80.67 -92.05 0.05 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 119.438 1.017 . . . . 0.0 112.312 -179.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.8 m -141.24 131.44 24.9 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 120.259 1.391 . . . . 0.0 109.218 -178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 122.957 1.361 . . . . 0.0 111.258 179.192 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.208 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.1 tt -78.69 128.84 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 O-C-N 124.122 0.889 . . . . 0.0 111.337 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 72.8 t90 -147.28 115.3 6.52 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.46 90.49 0.19 Allowed Glycine 0 N--CA 1.482 1.738 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 178.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.35 114.85 15.49 Favored 'General case' 0 N--CA 1.489 1.525 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 95.2 p -144.06 173.56 11.62 Favored 'General case' 0 CA--C 1.571 1.767 0 C-N-CA 123.487 0.715 . . . . 0.0 110.648 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 178.02 -99.1 0.12 Allowed Glycine 0 N--CA 1.482 1.701 0 O-C-N 120.495 -1.378 . . . . 0.0 112.917 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -82.12 -64.14 1.24 Allowed 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 113.704 1.002 . . . . 0.0 113.704 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.7 tp -140.15 -58.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 118.843 0.747 . . . . 0.0 112.259 -179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.8 tp -135.64 89.07 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 CA-C-N 119.058 0.844 . . . . 0.0 110.732 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 41.1 p -115.01 137.28 52.18 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.599 0.714 . . . . 0.0 110.226 -179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.3 m -87.09 106.96 18.22 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.278 0 CA-C-O 122.886 1.327 . . . . 0.0 112.424 -179.897 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.097 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 7.6 tp -134.68 93.44 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 124.236 0.96 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 4.2 p90 -152.41 124.59 8.11 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.38 -63.53 1.67 Allowed Glycine 0 N--CA 1.492 2.371 0 CA-C-N 116.452 -0.34 . . . . 0.0 113.832 -179.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -102.72 108.44 19.69 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 105.776 -1.935 . . . . 0.0 105.776 179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.335 79.9 p -86.19 -116.74 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 CA-C-O 118.399 -0.81 . . . . 0.0 111.087 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.0 -78.81 1.92 Allowed Glycine 0 N--CA 1.485 1.945 0 CA-C-N 120.261 1.391 . . . . 0.0 114.666 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -110.64 -163.6 0.86 Allowed 'General case' 0 CA--C 1.57 1.731 0 C-N-CA 124.115 0.966 . . . . 0.0 112.035 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.55 -25.06 36.16 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.79 96.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 N-CA-C 106.377 -1.712 . . . . 0.0 106.377 179.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 86.5 m -136.1 94.39 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.3 m -139.43 103.29 4.68 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.355 -1.721 . . . . 0.0 106.355 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.336 0 CA-C-O 122.799 1.285 . . . . 0.0 112.528 -179.833 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.211 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.5 tp -147.07 97.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 46.1 t90 -149.13 109.12 4.08 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 179.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 179.47 76.95 0.06 OUTLIER Glycine 0 N--CA 1.48 1.597 0 N-CA-C 111.886 -0.486 . . . . 0.0 111.886 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -160.34 122.99 3.33 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 -179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.5 p -148.22 167.44 25.1 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 123.415 0.686 . . . . 0.0 110.465 178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.26 -99.51 0.13 Allowed Glycine 0 N--CA 1.48 1.619 0 O-C-N 120.326 -1.484 . . . . 0.0 112.8 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -91.36 -68.88 0.77 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 118.702 -0.666 . . . . 0.0 112.322 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -145.99 -66.08 0.3 Allowed 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 119.159 0.89 . . . . 0.0 110.963 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.337 9.7 tp -95.51 79.86 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 118.882 0.764 . . . . 0.0 112.112 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.7 t -152.1 131.14 12.62 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.095 0.474 . . . . 0.0 110.136 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 51.6 m -100.42 112.61 24.98 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 124.195 1.95 . . . . 0.0 111.999 -179.925 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.247 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.7 101.34 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 54.7 t-105 -152.11 102.97 2.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 161.26 71.88 0.02 OUTLIER Glycine 0 CA--C 1.54 1.626 0 CA-C-O 119.634 -0.536 . . . . 0.0 114.026 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -155.42 101.73 2.21 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 178.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 98.8 p -129.71 178.75 6.27 Favored 'General case' 0 N--CA 1.498 1.953 0 C-N-CA 123.286 0.635 . . . . 0.0 111.798 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.37 -95.7 0.1 OUTLIER Glycine 0 N--CA 1.482 1.761 0 N-CA-C 110.152 -1.179 . . . . 0.0 110.152 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.4 mtmt -83.08 -65.24 1.03 Allowed 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 122.956 0.502 . . . . 0.0 110.425 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.5 tp -121.78 -83.99 0.66 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.2 pp -128.15 109.18 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 52.4 m -141.39 -72.17 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.634 1.106 . . . . 0.0 109.382 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.7 t -125.71 75.73 1.51 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.701 0.762 . . . . 0.0 111.13 -178.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 123.203 1.477 . . . . 0.0 109.957 179.458 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.206 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 tp -147.9 103.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -126.86 88.31 2.8 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.64 -64.44 2.16 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 115.912 1.125 . . . . 0.0 115.912 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.368 0.0 OUTLIER -133.74 -33.89 1.05 Allowed 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 54.7 p -150.81 -163.97 1.9 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.583 1.083 . . . . 0.0 110.714 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.12 68.86 3.45 Favored Glycine 0 N--CA 1.487 2.056 0 O-C-N 121.004 -1.06 . . . . 0.0 113.831 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -151.82 124.83 8.61 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 105.24 -2.134 . . . . 0.0 105.24 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.32 4.4 pp -51.17 -26.94 7.59 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 119.932 3.308 . . . . 0.0 119.932 -179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.279 10.7 tp -133.3 84.92 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 CA-C-N 119.433 1.015 . . . . 0.0 110.299 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 m -112.42 101.71 9.88 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 179.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.6 m -139.41 110.82 7.03 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 124.308 2.004 . . . . 0.0 110.73 -179.881 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.288 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -145.74 96.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 124.024 0.828 . . . . 0.0 108.988 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 67.0 t-105 -150.75 103.54 3.1 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 105.47 -2.048 . . . . 0.0 105.47 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 86.11 -74.74 2.35 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 112.116 -0.393 . . . . 0.0 112.116 -178.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . 0.274 5.0 tm-20 -119.06 -60.05 1.79 Allowed 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 124.447 1.099 . . . . 0.0 110.358 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.271 91.5 p -150.06 -138.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 123.721 0.808 . . . . 0.0 108.866 178.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.26 94.1 0.09 OUTLIER Glycine 0 N--CA 1.48 1.572 0 O-C-N 120.777 -1.202 . . . . 0.0 112.0 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.256 21.6 ptmt -143.84 -68.29 0.33 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 123.495 0.718 . . . . 0.0 109.796 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.3 mt -115.39 -71.43 0.74 Allowed 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 106.756 -1.572 . . . . 0.0 106.756 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 9.6 tp -149.43 90.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 99.7 m -137.13 106.01 5.92 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 107.437 -1.319 . . . . 0.0 107.437 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 89.4 m -142.23 97.9 3.21 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 105.358 -2.09 . . . . 0.0 105.358 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 124.217 1.961 . . . . 0.0 111.144 -179.642 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.07 96.96 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 N-CA-C 106.811 -1.552 . . . . 0.0 106.811 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.8 t90 -155.38 115.5 3.76 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -92.43 100.26 2.64 Favored Glycine 0 N--CA 1.49 2.234 0 O-C-N 121.849 -0.532 . . . . 0.0 114.246 -178.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.88 115.11 3.54 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 89.1 p -131.01 161.82 31.12 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 123.357 0.663 . . . . 0.0 110.593 178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.33 -93.07 0.09 OUTLIER Glycine 0 N--CA 1.482 1.734 0 O-C-N 120.343 -1.473 . . . . 0.0 112.741 -179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . 0.258 61.0 pttt -70.69 -67.22 0.52 Allowed 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 113.827 1.047 . . . . 0.0 113.827 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.36 1.5 pt? -149.58 -59.84 0.21 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.731 0.813 . . . . 0.0 110.024 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 33.1 mm -129.04 90.24 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.1 t -73.38 131.01 41.37 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 121.544 1.975 . . . . 0.0 114.172 -178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 83.6 m -141.18 98.91 3.47 Favored 'General case' 0 CA--C 1.559 1.301 0 N-CA-C 104.993 -2.225 . . . . 0.0 104.993 179.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.305 0 CA-C-O 122.911 1.338 . . . . 0.0 112.46 -179.604 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.204 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.1 tp -146.37 99.91 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 107.494 -1.299 . . . . 0.0 107.494 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 56.6 t-105 -155.48 108.89 2.78 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -94.13 91.94 1.51 Allowed Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -146.84 111.8 5.38 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 -179.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 61.2 p -115.81 82.15 1.72 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.54 -92.84 0.9 Allowed Glycine 0 N--CA 1.484 1.888 0 O-C-N 120.838 -1.164 . . . . 0.0 113.28 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -97.71 -70.81 0.71 Allowed 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 122.994 0.518 . . . . 0.0 111.072 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.6 tp -141.67 -68.59 0.38 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 118.866 0.757 . . . . 0.0 109.478 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -101.82 90.59 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.8 m -141.33 110.64 6.32 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 85.9 m -138.51 91.49 2.55 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.358 0 CA-C-O 122.753 1.263 . . . . 0.0 113.189 -179.573 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.181 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -148.27 97.46 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.3 t-105 -151.47 109.74 3.75 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -91.01 105.22 3.25 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 111.93 -0.468 . . . . 0.0 111.93 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -125.41 113.52 17.63 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.273 93.9 p -136.69 -126.32 0.14 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 118.745 -0.645 . . . . 0.0 109.372 179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.97 -78.82 1.97 Allowed Glycine 0 N--CA 1.487 2.043 0 CA-C-N 120.062 1.301 . . . . 0.0 112.174 -178.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -85.7 153.24 22.47 Favored 'General case' 0 CA--C 1.566 1.56 0 C-N-CA 123.937 0.895 . . . . 0.0 110.117 178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.25 4.5 pp -55.57 -22.12 20.44 Favored 'General case' 0 N--CA 1.499 1.985 0 N-CA-C 118.672 2.842 . . . . 0.0 118.672 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.252 0.0 OUTLIER -134.87 90.82 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 N-CA-C 105.542 -2.021 . . . . 0.0 105.542 177.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.3 t -148.54 131.56 16.27 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 123.485 0.714 . . . . 0.0 109.089 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.0 m -94.8 102.71 14.59 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.251 0 CA-C-O 124.103 1.906 . . . . 0.0 108.992 -179.798 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.218 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.8 tp -143.48 99.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 124.158 0.911 . . . . 0.0 108.641 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.3 p90 -131.29 91.28 3.0 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.52 -82.96 0.05 OUTLIER Glycine 0 N--CA 1.481 1.657 0 N-CA-C 109.846 -1.301 . . . . 0.0 109.846 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -151.16 94.87 2.1 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 92.2 p -153.04 166.59 31.96 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 122.996 0.518 . . . . 0.0 110.849 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 115.96 114.36 2.87 Favored Glycine 0 CA--C 1.543 1.82 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -178.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 37.2 ttpt -54.69 -55.84 25.53 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 26.2 mt -79.58 -61.06 2.12 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.13 0.572 . . . . 0.0 110.449 178.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -101.57 101.19 11.76 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.586 0 C-N-CA 124.011 0.925 . . . . 0.0 109.24 179.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.6 m -124.53 -74.52 0.61 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 -179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 40.0 p -133.25 -61.55 0.82 Allowed 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 123.92 0.888 . . . . 0.0 110.383 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.328 0 CA-C-O 122.808 1.29 . . . . 0.0 112.842 179.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.269 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.2 tp -144.1 106.02 0.95 Allowed 'Isoleucine or valine' 0 CA--C 1.566 1.564 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 19.9 m-90 -93.26 84.48 4.79 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.373 1.083 . . . . 0.0 108.22 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.39 -72.24 0.04 OUTLIER Glycine 0 CA--C 1.538 1.528 0 CA-C-N 114.281 -1.327 . . . . 0.0 109.974 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -158.35 128.76 6.13 Favored 'General case' 0 CA--C 1.563 1.463 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 83.3 p -127.02 -129.05 0.23 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.25 70.49 0.03 OUTLIER Glycine 0 N--CA 1.484 1.893 0 CA-C-N 119.969 1.259 . . . . 0.0 114.434 179.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -143.9 -76.64 0.23 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 179.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.2 tp -125.89 -80.07 0.61 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 104.019 -2.585 . . . . 0.0 104.019 177.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 11.2 tt -78.59 117.79 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.301 13.6 t -75.83 -59.15 2.88 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 116.708 2.114 . . . . 0.0 116.708 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 69.4 m -90.11 77.28 6.82 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-N 119.614 1.097 . . . . 0.0 110.257 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.266 0 CA-C-O 122.944 1.354 . . . . 0.0 111.071 -179.394 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.188 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -143.58 99.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 124.151 0.907 . . . . 0.0 108.791 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 28.0 p90 -128.44 89.32 2.88 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.61 -78.16 0.07 OUTLIER Glycine 0 N--CA 1.481 1.671 0 CA-C-N 115.584 -0.734 . . . . 0.0 112.049 -179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -116.31 83.3 1.93 Allowed 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 106.733 -1.581 . . . . 0.0 106.733 179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 65.1 p -154.24 104.9 2.64 Favored 'General case' 0 CA--C 1.567 1.625 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.44 120.56 0.68 Allowed Glycine 0 CA--C 1.541 1.695 0 CA-C-N 121.065 1.757 . . . . 0.0 111.448 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -58.89 -52.97 63.46 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.4 tp -78.29 -75.96 0.21 Allowed 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 178.023 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 4.8 tt -90.61 125.13 43.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.5 m -62.99 -69.22 0.28 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.194 1.361 . . . . 0.0 112.269 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.9 m -150.04 107.05 3.56 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 122.915 1.341 . . . . 0.0 111.428 179.53 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.23 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.2 102.44 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 28.9 m-90 -93.45 82.91 4.46 Favored 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.468 1.128 . . . . 0.0 109.203 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -162.67 -83.84 0.05 OUTLIER Glycine 0 CA--C 1.537 1.407 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.962 -179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -124.51 94.9 4.34 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 81.0 p -160.98 149.54 16.24 Favored 'General case' 0 CA--C 1.568 1.67 0 C-N-CA 123.853 0.861 . . . . 0.0 110.091 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 112.04 125.98 4.65 Favored Glycine 0 CA--C 1.546 1.997 0 O-C-N 120.649 -1.282 . . . . 0.0 112.085 -179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.8 mtmt -64.88 -50.88 64.83 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.1 mt -77.21 -59.1 2.92 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 118.73 0.696 . . . . 0.0 111.15 178.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 34.1 mm -107.71 92.36 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 179.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.0 p -81.46 100.06 9.1 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.838 1.199 . . . . 0.0 109.489 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 p -91.37 -63.36 1.27 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 118.499 -0.762 . . . . 0.0 111.487 -179.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 124.502 2.096 . . . . 0.0 108.796 179.345 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.186 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 tp -147.69 105.13 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.567 1.608 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 40.8 t-105 -138.38 95.29 2.97 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.34 -88.66 0.07 OUTLIER Glycine 0 N--CA 1.482 1.721 0 N-CA-C 108.531 -1.827 . . . . 0.0 108.531 -179.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.9 59.52 0.73 Allowed 'General case' 0 N--CA 1.5 2.039 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.2 p -179.1 -97.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.62 -82.39 1.42 Allowed Glycine 0 C--N 1.355 1.603 0 CA-C-N 119.566 1.075 . . . . 0.0 115.716 177.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -147.83 -57.97 0.24 Allowed 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.5 tp -128.55 -72.89 0.6 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 119.302 0.956 . . . . 0.0 109.405 -179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 8.3 tt -69.79 136.18 26.69 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.169 0 CA-C-N 118.788 0.722 . . . . 0.0 110.959 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 t -81.39 86.84 6.22 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 120.062 1.301 . . . . 0.0 110.042 178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 96.7 m -140.87 89.6 2.27 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 124.533 2.111 . . . . 0.0 110.895 -179.268 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.212 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.7 tp -145.13 87.15 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 124.135 0.897 . . . . 0.0 108.718 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 45.3 t90 -113.85 100.69 8.63 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.42 -89.56 2.11 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 111.992 -0.443 . . . . 0.0 111.992 -179.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -109.93 97.07 6.66 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.0 p -161.53 178.74 8.81 Favored 'General case' 0 N--CA 1.493 1.714 0 C-N-CA 123.42 0.688 . . . . 0.0 111.249 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.72 -76.77 0.12 Allowed Glycine 0 N--CA 1.482 1.729 0 O-C-N 120.78 -1.2 . . . . 0.0 112.689 -179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -70.95 -60.42 2.24 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.379 1.252 . . . . 0.0 114.379 -179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 tt -126.47 -98.22 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . 0.25 6.6 tp -146.01 94.37 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 CA-C-N 119.266 0.939 . . . . 0.0 109.843 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.0 m -126.17 -72.63 0.65 Allowed 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.6 t -152.64 133.39 13.95 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 123.524 0.73 . . . . 0.0 110.099 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.433 0 CA-C-O 122.828 1.299 . . . . 0.0 112.394 179.841 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.198 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 16.7 mm -146.91 109.62 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 N-CA-C 103.399 -2.815 . . . . 0.0 103.399 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.2 t-105 -153.34 110.55 3.48 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.54 90.65 1.64 Allowed Glycine 0 N--CA 1.489 2.203 0 CA-C-O 120.169 -0.24 . . . . 0.0 112.887 179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.61 110.62 4.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 -179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 63.7 p -118.06 85.32 2.33 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.915 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.78 -91.76 0.78 Allowed Glycine 0 C--N 1.36 1.871 0 CA-C-N 119.763 1.165 . . . . 0.0 113.063 179.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 23.5 ttmm -98.46 -80.91 0.45 Allowed 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 118.452 -0.785 . . . . 0.0 109.651 179.719 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 35.8 mt -118.64 -72.63 0.68 Allowed 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.648 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 2.3 pp -108.21 111.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 15.2 t -151.1 126.02 9.76 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 120.976 0.417 . . . . 0.0 110.733 -179.677 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 41.3 p -136.24 76.28 1.59 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.023 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.269 0 CA-C-O 124.159 1.933 . . . . 0.0 110.987 -179.567 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.195 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 5.8 tp -147.91 100.72 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 62.6 t-105 -142.41 106.9 4.8 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 179.263 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -119.65 94.13 0.56 Allowed Glycine 0 N--CA 1.482 1.704 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -118.51 72.31 0.87 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.954 0.883 . . . . 0.0 109.644 179.32 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.2 p -163.14 87.65 0.57 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.957 -1.868 . . . . 0.0 105.957 179.21 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.07 68.99 1.48 Allowed Glycine 0 N--CA 1.491 2.313 0 CA-C-N 121.396 1.907 . . . . 0.0 112.6 -177.664 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -141.43 141.85 33.71 Favored 'General case' 0 N--CA 1.488 1.446 0 C-N-CA 123.348 0.659 . . . . 0.0 110.884 -177.673 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.57 -38.55 81.43 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 177.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 6.5 tp -119.65 99.28 7.41 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.453 0 N-CA-C 103.07 -2.937 . . . . 0.0 103.07 176.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 10.0 t -84.68 98.41 10.19 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.49 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 94.9 m -92.54 106.48 18.46 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 -179.119 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 122.782 1.277 . . . . 0.0 113.468 -179.564 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.165 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 tt -106.04 132.52 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 124.264 0.978 . . . . 0.0 111.599 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.4 m-90 -93.03 86.79 5.52 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.71 -110.43 0.44 Allowed Glycine 0 CA--C 1.538 1.481 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -163.26 130.27 3.45 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 117.583 0.691 . . . . 0.0 110.943 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.261 95.7 p -141.23 -121.47 0.11 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 177.949 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.53 78.48 0.11 Allowed Glycine 0 N--CA 1.482 1.71 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 179.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -152.09 -166.07 2.39 Favored 'General case' 0 CA--C 1.569 1.697 0 C-N-CA 123.881 0.872 . . . . 0.0 110.545 -178.455 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.28 -25.35 67.04 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 177.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 7.5 tp -132.45 94.28 1.81 Allowed 'Isoleucine or valine' 0 CA--C 1.565 1.534 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 177.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.7 m -119.73 104.29 10.11 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.668 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 27.5 m -91.87 119.46 31.67 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.177 0 CA-C-O 124.434 2.064 . . . . 0.0 108.861 179.675 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.192 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . 0.367 9.1 tp -94.64 74.78 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.296 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.6 p90 -143.24 90.45 2.18 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 105.17 -2.159 . . . . 0.0 105.17 176.709 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 114.93 100.95 2.34 Favored Glycine 0 N--CA 1.482 1.737 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 -177.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -103.4 93.23 4.85 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -179.376 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.4 m -158.19 159.42 36.1 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 123.325 0.65 . . . . 0.0 110.488 179.78 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.21 115.08 3.75 Favored Glycine 0 N--CA 1.485 1.915 0 O-C-N 120.88 -1.137 . . . . 0.0 112.033 -179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 18.9 ptpt -62.03 -44.86 95.81 Favored 'General case' 0 N--CA 1.498 1.958 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 179.073 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.5 tp -74.64 -48.51 25.92 Favored 'General case' 0 CA--C 1.57 1.717 0 C-N-CA 123.525 0.73 . . . . 0.0 112.509 177.847 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 5.9 tp -128.72 101.7 7.11 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.505 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 178.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 54.1 m -74.73 103.57 5.05 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 119.408 1.004 . . . . 0.0 108.723 179.035 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.7 p -125.01 112.54 16.68 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -179.09 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.202 0 CA-C-O 124.265 1.983 . . . . 0.0 111.499 -179.722 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.0 tp -149.23 103.88 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.5 m-90 -127.35 92.37 3.49 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.37 -117.09 0.51 Allowed Glycine 0 N--CA 1.49 2.238 0 CA-C-N 115.705 -0.68 . . . . 0.0 113.833 179.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -145.36 131.46 19.36 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 117.521 0.66 . . . . 0.0 111.336 -179.184 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . 0.272 20.5 m -130.29 -113.01 0.25 Allowed 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 117.133 -1.413 . . . . 0.0 107.199 178.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.8 -80.47 0.08 OUTLIER Glycine 0 N--CA 1.483 1.808 0 CA-C-N 122.141 2.246 . . . . 0.0 116.915 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -52.41 -60.51 3.15 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 117.476 2.399 . . . . 0.0 117.476 -177.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 44.6 tp -75.62 -62.07 1.71 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.127 0.876 . . . . 0.0 112.45 179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 3.2 tp -150.6 128.06 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.434 0 N-CA-C 106.475 -1.676 . . . . 0.0 106.475 179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' DAB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 p -76.57 86.57 3.26 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 121.199 1.818 . . . . 0.0 112.033 -179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 11.2 t -168.77 139.11 2.39 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 124.807 1.243 . . . . 0.0 107.816 179.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 122.801 1.286 . . . . 0.0 112.765 179.866 . . . . . . . . 0 0 . 1 stop_ save_